Literature DB >> 2482282

Effect of adriamycin on DNA, RNA and protein biosyntheses in mouse tissues, in connection with its cardiotoxicity.

Y Sazuka1, H Tanizawa, Y Takino.   

Abstract

We examined whether the cause of the remarkable decreases in the activities of lipid peroxidation-preventive enzymes in the heart of adriamycin (ADR)-treated mice might be related to inhibition of DNA, RNA or protein biosynthesis. It was found that biosyntheses of DNA, RNA and protein in the heart, liver and kidney of mice were markedly inhibited by ADR (15 mg/kg, ip). The inhibitory effects of ADR on each type of biosynthesis were particularly marked in the heart among the tissues examined. Strong correlations between the percentage inhibition of DNA and protein biosynthesis by ADR, and the percentage decrease in the activities of lipid peroxidation-preventive enzymes were observed in the heart, liver, kidney and lung, especially for the decrease of glutathione peroxidase activity and the inhibition of DNA and protein biosyntheses. We also found that marked decreases of DNA, RNA and protein biosynthesis in ADR-treated mice occurred not only in the heart but also in tumor tissues. From these results, we conclude that the increment of cardiac lipid peroxide in ADR-treated mice, which is closely related to the cardiotoxicity of ADR, results from inhibition of DNA, RNA and protein biosyntheses after the distribution of ADR.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2482282      PMCID: PMC5917886          DOI: 10.1111/j.1349-7006.1989.tb01640.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  21 in total

1.  Phosphorus compounds in animal tissues; a comparison of methods for the estimation of nucleic acids.

Authors:  W C SCHNEIDER
Journal:  J Biol Chem       Date:  1946-08       Impact factor: 5.157

2.  A method for the determination of desoxyribonucleic acid, ribonucleic acid, and phosphoproteins in animal tissues.

Authors:  G SCHMIDT; S J THANNHAUSER
Journal:  J Biol Chem       Date:  1945       Impact factor: 5.157

3.  Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin.

Authors:  J Goodman; P Hochstein
Journal:  Biochem Biophys Res Commun       Date:  1977-07-25       Impact factor: 3.575

4.  Adriamycin (NSC-123,127): a new antibiotic with antitumor activity.

Authors:  A Di Marco; M Gaetani; B Scarpinato
Journal:  Cancer Chemother Rep       Date:  1969-02

5.  Change of lipid peroxide levels in mouse organs after adriamycin administration.

Authors:  H Tanizawa; Y Sazuka; Y Takino
Journal:  Chem Pharm Bull (Tokyo)       Date:  1983-05       Impact factor: 1.645

6.  Heart mitochondrial DNA synthesis: preferential inhibition by adriamycin.

Authors:  S C Hixon; C N Ellis; J P Daugherty
Journal:  J Mol Cell Cardiol       Date:  1981-09       Impact factor: 5.000

7.  Superoxide anion production by adriamycinol from cardiac sarcosomes and by mitochondrial NADH dehydrogenase.

Authors:  P G Gervasi; M R Agrillo; L Citti; R Danesi; M Del Tacca
Journal:  Anticancer Res       Date:  1986 Sep-Oct       Impact factor: 2.480

8.  Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity.

Authors:  S Rajagopalan; P M Politi; B K Sinha; C E Myers
Journal:  Cancer Res       Date:  1988-09-01       Impact factor: 12.701

9.  Repair kinetics of DNA, RNA and proteins in the tissues of mice treated with doxorubicin.

Authors:  E Arena; N D'Alessandro; L Dusonchet; M Geraci; L Rausa; R Sanguedolce
Journal:  Arzneimittelforschung       Date:  1979

10.  Effect of adriamycin on heart mitochondrial DNA.

Authors:  C N Ellis; M B Ellis; W S Blakemore
Journal:  Biochem J       Date:  1987-07-01       Impact factor: 3.857

View more
  4 in total

1.  Doxorubicin cardiotoxicity is associated with alterations of plasma levels of atrial natriuretic factor.

Authors:  N Bernardini; C Agen; S Favilla; R Danesi; M Del Tacca
Journal:  J Endocrinol Invest       Date:  1992-02       Impact factor: 4.256

2.  Effect of CPT-11 on lipid peroxide level in mouse tissues.

Authors:  Y Sadzuka; S Hirota
Journal:  Jpn J Cancer Res       Date:  1997-05

3.  1-Methyl-3-propyl-7-butylxanthine, a novel biochemical modulator, enhances therapeutic efficacy of adriamycin.

Authors:  Y Sadzuka; A Iwazaki; T Sugiyama; T Sawanishi; K Miyamoto
Journal:  Jpn J Cancer Res       Date:  1998-02

4.  Caffeine modulates the antitumor activity and toxic side effects of adriamycin.

Authors:  Y Sadzuka; E Mochizuki; Y Takino
Journal:  Jpn J Cancer Res       Date:  1993-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.